NeuroMetrix, Inc. (NURO)
May 1, 2025 - NURO was delisted (reason: acquired by ECOR)
4.580
0.00 (0.00%)
Inactive · Last trade price on May 1, 2025
NeuroMetrix Revenue
In the year 2024, NeuroMetrix had annual revenue of $3.03M, down -48.61%. NeuroMetrix had revenue of $582.82K in the quarter ending December 31, 2024, a decrease of -55.77%.
Revenue (ttm)
$3.03M
Revenue Growth
-48.61%
P/S Ratio
n/a
Revenue / Employee
$233,295
Employees
13
Market Cap
n/a
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.03M | -2.87M | -48.61% |
| Dec 31, 2023 | 5.90M | -2.35M | -28.52% |
| Dec 31, 2022 | 8.26M | 2.58K | 0.03% |
| Dec 31, 2021 | 8.25M | 875.52K | 11.87% |
| Dec 31, 2020 | 7.38M | -1.89M | -20.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNURO News
- 10 months ago - NEUROMETRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeuroMetrix, Inc. - NURO - Business Wire
- 11 months ago - NeuroMetrix to be Acquired by electroCore - GlobeNewsWire
- 1 year ago - NeuroMetrix Reiterates its Review of Strategic Alternatives - GlobeNewsWire
- 1 year ago - NeuroMetrix, Inc. (NURO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call - GlobeNewsWire
- 1 year ago - NeuroMetrix Reports Q1 2024 Business Highlights - GlobeNewsWire
- 1 year ago - NeuroMetrix Announces Steps Taken to Enhance Shareholder Value - GlobeNewsWire
- 1 year ago - NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy - GlobeNewsWire